CRISM Therapeutics Corporation

AIM:CRTX Stock Report

Market Cap: UK£3.1m

CRISM Therapeutics Balance Sheet Health

Financial Health criteria checks 4/6

CRISM Therapeutics has a total shareholder equity of £2.1M and total debt of £0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are £2.4M and £351.0K respectively.

Key information

0%

Debt to equity ratio

UK£0

Debt

Interest coverage ration/a
CashUK£1.86m
EquityUK£2.07m
Total liabilitiesUK£351.00k
Total assetsUK£2.42m

Recent financial health updates

Amur Minerals (LON:AMC) Is In A Good Position To Deliver On Growth Plans

Mar 07
Amur Minerals (LON:AMC) Is In A Good Position To Deliver On Growth Plans

Recent updates

Amur Minerals (LON:AMC) Is In A Good Position To Deliver On Growth Plans

Mar 07
Amur Minerals (LON:AMC) Is In A Good Position To Deliver On Growth Plans

Financial Position Analysis

Short Term Liabilities: CRTX's short term assets (£2.3M) exceed its short term liabilities (£351.0K).

Long Term Liabilities: CRTX has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: CRTX is debt free.

Reducing Debt: CRTX has no debt compared to 5 years ago when its debt to equity ratio was 5.5%.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: CRTX has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: CRTX has less than a year of cash runway if free cash flow continues to grow at historical rates of 8.6% each year.


Discover healthy companies